FDA reform needs to be underpinned by strategy, not ‘indiscriminate’ cuts The Trump administration could save the lives of ...

US cost-effectiveness watchdog ICER has handed bluebird bio some good news ahead of its FDA advisory committee meeting for rare blood disorder gene therapy beti-cel in June, by endorsing its ...

Zevra has sold its US Food and Drug Administration (FDA) priority review voucher (PRV) for $150m to an undisclosed party. The ...

Corporation announced that Anne De Greef-Safft has joined its Board of Directors, effective February 25, 2025. From 2018 to 2024, ...

Gene therapy maker bluebird bio’s 15-year flight has landed in the nest of private equity firms Carlyle and SK Capital in a ...

Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...

Lentiviral Vectors Market Size 2025 Lentiviral Vectors Market is estimated to be valued at US$ 292 million in 2023 and is expected to exhib ...

Hughesnet's subscriber base drops below 1 million despite its new Jupiter 3 satellite facilitating faster speeds. Still, its quarter-over-quarter decline was not as bad as last year's numbers.